NCT06758882View on ClinicalTrials.gov

Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET

PHASE2RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
High Risk Prostate Cancer
Interventions
DRUG

Apalutamide

administration of non steroid androgenic receptor inhibitors plus androgen deprivation therapy

DRUG

Androgen receptor (AR) inhibitor

administration of androgen deprivation therapy

Trial Locations (1)

10126

RECRUITING

Dept of Surgical Sciences - Urology, Molinette Hospital, University of Torino, Torino

All Listed Sponsors
lead

Marco Oderda

OTHER